Abstract: Current hypothesis of neuronal degeneration in Parkinson's disease (PD) have been proposed, including formation of free radicals and oxidative stress, mitochondrial dysfunction, excitotoxicity, trophic factor deficiency, inflammatory processes, genetic factors, environmental impact factors, toxic action of nitric oxide, apoptosis, and so on. This review mainly discussed oxidative stress, environmental impact factors, and inflammatory processes in PD.
Introduction
Various mechanisms of neuronal degeneration in Parkinson's disease (PD) have been proposed. These include formation of free radicals and oxidative stress, mitochondrial dysfunction, excitotoxicity, calcium cytotoxicity, trophic factor deficiency, inflammatory processes, genetic factors, environmental impact factors, toxic action of nitric oxide and apoptosis-all of which may interact and amplify each other in a vicious cycle of toxicity leading to neuronal dysfunction, atrophy, and finally cell death ( Fig. 1 ) [1] [2] [3] [4] . In this review we mainly discussed the oxidative stress, environmental impact factors, and inflammatory processes in PD.
Oxidative stress
The "oxidative stress" hypothesis infers an imbalance between the formation of cellular oxidants and the antioxidative processes (Fig. 2) . Oxidative stress, due to the excessive formation of hydrogen peroxide and oxygenderived free radicals, such as hydroxyl (OH·) and superoxide (O 2 ·) radicals, can cause cell damage due to chain reaction of membrane lipid peroxidation and/or alterations in membrane fluidity [5] (Fig. 3) .
In dopaminergic neurons, dopamine (DA) breakdown can occur spontaneously in the presence of iron, or can be catalysed by monoamine oxidase (MAO) in a reaction that generates hydrogen peroxide (H 2 O 2 ). Even though H 2 O 2 does not damage cells, the formation of hydroxyl radicals by the Fenton reaction can lead to cytotoxicity. Normally, cells scavenge these deleterious molecules using several antioxidant systems. For instance, glutathione (GSH) peroxidase detoxifies H 2 O 2 using reduced GSH. Oxidized glutathione (GSSG) can be reduced by GSSG reductase and reused. GSH-S-transferase converts electrophilic centres of various potentially toxic compounds to thioether bonds. Superoxide dismutase (SOD) converts superoxide to H 2 O 2 . Catalase, in turn, converts H 2 O 2 to molecular oxygen and water (Fig. 2) .
Compared with the rest of the brain, the substantia nigra pars compacta (SNpc) is exposed to higher level of oxidative stress and a high rate of reactive oxygen species (ROS) formation. The reason for this is not clear, but may be related to the energy metabolism of these cells or to their high content of DA. Post-mortem studies in the parkinsonian brain indicate that DA neurons may be deficient in handling oxidative stress [6] . This is believed to reflect both increased generation of free radicals and impairments in the mechanisms for scavenging them: a 30%-60% decrease in GSSG in the SN of parkinsonian patients, in conjunction with increased levels of iron. Also, various markers of lipid peroxidation and protein oxidation damage to DNA are increased in the SN. Oxidative stress may also account for the nigral defect of complex I activity, in that complex I is highly vulnerable to oxidative damage and inhibition of complex I leads to increased ROS formation. Toxic products of oxidative changes may be important contributors to disease progression [7] .
Although post-mortem investigations and experimental impact studies showed that oxidative stress has relevance to PD, it is not known how this process relates to the time course of neuronal degeneration in SN or how oxidative stress relates to the other processes known to be involved in the cascade of events leading to dopaminergic cell death (which comes first, the chicken or the egg?). This situation has so far proved impossible to be resolved [9] . In addition, Oxidative stress may contribute to impairment of the ubiquitin-proteasome system (UPS) [10] , and in turn, impairment of the UPS may cause oxidative stress.
Environmental impact factors
Epidemiological studies have shown that environmental impact factors may play roles in the PD process (Tab. 1).
The involvement of pesticides exposure (paraquat, organochlorines, carbamates, etc.) has been strongly implicated in the development of sporadic PD [13, 14] . Rural living is usually associated with the agricultural industry, and work in this environment also has been suggested to increase the risk of developing PD. Rotenone is a widely available and commonly used pesticide, often used to control fish stocks in reservoirs, that is a potent complex I inhibitor. A recent report notes that the systemic infusion of rotenone into rats induces selective dopaminergic cell death, intraneuronal ubiquitin rich protein inclusions (Lewy bodies) and a motor deficit. These findings add to the idea that environmental impact factors may cause or contribute to PD [15] . Metals have recently been shown to interact withsynuclein and to promote its fibrillation in vitro [16] . Longterm and combined (e.g. lead with iron, iron with copper, manganese) exposures increase the risk of PD [12, 17] . Overall, however, epidemiological evidence in support on a relation between metal exposure and PD remains inconclusive [18] . Epidemiological studies have indicated that certain factors, such as caffeine consumption, may decrease the risk of PD [19] . They have also identified one undisputed factor that is inversely associated with PD: cigarette smoking. The effect of smoking has been estimated to de- crease risk of PD by up to 50%, is dependent on lifetime dose, and cannot be simply explained by selective mortality [20] . An important goal of future research will be to identify the specific compounds (such as nicotine), or mixture of compounds, that mediate the protective effects of smoking.
Neuroinflammatory processes
The hypothesis that neuroinflammation occurs in PD is supported by several lines of evidence (summarized in Fig. 4 ) [21] . One of the first features of the inflammatoryassociated modifications described in PD is the upregulated expression of major histocompatibility complex (MHC) molecules in the striatum and SNpc of mice intoxicated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Secondly, a marked increase in cytokine levels in the striatum and cerebrospinal fluid (CSF) of parkinsonian patients compared with control subjects has been observed [22, 23] .
These cytokines include: proinflammatory cytokines [tumor necrosis factor (TNF-), interlukin (IL)-1 , IL-6)], T-cell activation-associated cytokine (IL-2), anti-inflammatory cytokine (IL-4)
, and several growth factors [Epidermal growth factor (EGF), transforming growth factor (TGF-), basic fibroblast growth factor (bFGF), TGF-1]. Because an increase in the level of cytokines was specific to the nigrostriatal pathway and is not observed in cortical regions, it has been suggested that cytokine production may be strictly confined to the sites of injury [24] . There is recent evidence that inhibition of the ubiquitin-proteasome system can induce a proinflammatory response, manifested by upregulation of cyclo-oxygenase-2 (COX-2) [25] . However, how and when neuroinflammation arises in the course of PD and where inflammation participates in the cascade of events leading to nerve cell death have not yet been fully resolved (Fig. 5 ) [24] . To date, one of the best characterized cytotoxic mechanisms induced by pro-inflammatory cytokines in PD is the activation of inducible nitric oxide synthase (iNOS), which mediates the synthesis of high level of nitric oxide (NO), shown toxic to neurons [26] . Of relevance to the potential role of iNOS in the pathogenesis of PD is the demonstration that the density of glial cells expressing iNOS is markedly increased in the SN of parkinsonian patients compared with control subjects [27] . Other studies have shown proinflammatory cytokines [TNF-, IL-1 , and Interferon-(IFN-)] to be the most potent activators of iNOS in rodent glial cells. The hypothesis that this also might be the case in humans has been challenged. Recently, Hunot et al. [24] identified such a pathway in glial cells, involving cytokinestimulated expression of the low-affinity IgE receptor CD23 whose activation induced iNOS expression and subsequent high release of NO. Alternatively, cytokine-induced dopaminergic cell death may involve more direct cytotoxic mechanisms through direct activation of cytokine receptors localized in dopaminergic neurons and coupled to intracellular deathrelated signaling pathways. In PD, investigations primarily have been focused on TNF-receptors (TNF-RI). Engagement of TNF-RI has been shown to activate, in a cascade fashion, a group of cysteine proteases known as caspases that are central to the apoptotic machinery in mammalian cells [28, 29] . They are known to activate the ceramide (a breakdown product of the major cellular membrane phospholipid sphingomyelin) pathway, which can amplify the caspase pathway but also activate the transcription factor NF B through an oxidative stress-dependent mechanism.
Summary
In conclusion, neuroinflammation is an indisputable neuropathological feature of PD. Probably, the first indication that neuroinflammatory processes in the PD brain most likely arise secondary to a primary insult and quite possibly participate in the propagation of the neurodegenerative process. If true, this statement could have major therapeutic implications, as targeting specific neuroinflammatoryassociated deleterious mechanisms may prove effective in slowing or even halting the disease course [21] . Although the ultimate quest is to develop preventive treatments for PD, our best hope for now is probably to target secondary deleterious mechanisms [24] . In summary, the assertion that PD has a clinical and pathological end point common to a variety of different causes is now compelling. Inevitably, it is reasonable to hope that a clearer understanding of the cause and pathogenesis of PD will provide us with targets for treatments that provide modification and neuroprotection for the disease. 
